Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
11.46 USD | +1.19% | -7.17% | -47.07% |
04-15 | RBC Lowers Price Target on Nevro to $16 From $18, Keeps Sector Perform Rating | MT |
04-11 | Mizuho Adjusts Price Target on Nevro to $16 From $20, Maintains Neutral Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-47.07% | 415M | |
-2.33% | 187B | |
-1.74% | 106B | |
-4.32% | 66.9B | |
+0.52% | 49.45B | |
+16.18% | 48B | |
+4.06% | 40.84B | |
+3.28% | 26.48B | |
+1.12% | 26.25B | |
+12.96% | 24.62B |
- Stock Market
- Equities
- NVRO Stock
- News Nevro Corp.
- Sector Update: Health Care Stocks Sliding Thursday While Biotechs Advance